Treadmill Training and Quality of Life in Parkinson's Disease
Treadmill Walking Training With Additional Body Load Improves Quality of Life in Subjects With Parkinson's Disease
Parkinson's disease (PD) causes motor and non-motor impairments that affect the quality of life of the subjects. The purpose was to assess the effects of treadmill walking training with additional body load on the quality of life and motor symptoms of the subjects with PD.
Methods: Nine subjects with PD, Hoehn and Yahr stages 2 through 3, not demented and with capability to ambulate independently voluntarily participate in this study. The training program was divided into three phases (A1-B-A2): treadmill training with additional body load (A1), control condition (conventional physical therapy group) (B) and treadmill training with load again (A2). Each phase lasted six weeks. The quality of life and motor symptoms were assessed by PDQ-39 and UPDRS, respectively. Both evaluations and training were performed during on-phase of the medication cycle.
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
SP
-
São Carlos、SP、ブラジル、13565-905
- Universidade Federal de São Carlos
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Hoehn and Yahr (H-Y) stages 2 through 3
- Absence of dementia (Mini-Mental Status Examination - MMSE, defined according to educational level)
- Capacity to ambulate independently for at least 10 meters
Exclusion Criteria:
- Change medication (dopaminergic) during the study period
- Use treadmill for at least six months prior to the study
- Other neurologic problems or musculoskeletal, cardiovascular and respiratory disease or uncorrected visual deficit that could represent risk and interfere in the accomplishment of the training
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：なし
- 介入モデル：単一グループの割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：PD Group
Nine subjects with idiopathic PD, previously diagnosed by one specialist physician participated in this study.
|
The training program was divided into three phases (A1-B-A2):
Each phase lasted six weeks, totaling 18 weeks. Both evaluations and training were performed during on-phase of the medication cycle. |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
The quality of life was measured through Parkinson Disease Questionnaire (PDQ-39).
時間枠：4 times, once before treatment, and 3 after each treatment phase.
|
4 times, once before treatment, and 3 after each treatment phase.
|
協力者と研究者
捜査官
- 主任研究者：Nadiesca T Filippin, MSc、Universidade Federal de São Carlos
- スタディチェア：Rosana Mattioli, PhD、Universidade Federal de São Carlos
- スタディディレクター：Paula H Lobo da Costa, PhD、Universidade Federal de São Carlos
研究記録日
主要日程の研究
研究開始
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。